Epidiolex/Epidyolex Q3 sales.Up 21% to 160.4 million Q3 2021 produced by GW pharma which is being purchased by Pizer for 6.7 Billion. This recent FDA approved drug,( June 21 ) is pure CBD isolate no different than LABS CBD 100. The delivery method is even the same, as an oil and not a pill. Medipharm is challenging patents as stated in last update. Being the only FDA approved cannabis drug widely adopted globally and literally already selling it OTC obviously this is what they're after. I continue to bring this up because epidiolex a.k.a CBD isolate as a prescription pharmaceutical is a game changer to little medipharm who's only valued at 50m cdn presently and could already be supplying active pharmaceutical ingredients to complement demand and who will break the patent and soon have a generic alternative.